{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001829635","name":"Transcode Therapeutics, Inc.","summary":"TransCode Therapeutics is an RNA oncology company developing RNA-based therapeutics for cancer treatment. Its proprietary TTX drug delivery platform enables targeted delivery of oligonucleotides to tumors and metastases. Its lead candidate, TTX-MC138, targets microRNA-10b, a regulator of metastatic cell viability across multiple cancers including breast, pancreatic, ovarian, and colon. The company has received FDA authorization and is conducting a Phase I/II clinical trial with TTX-MC138 in patients with advanced solid tumors.","people":[],"products":[{"name":"TTX Platform","type":"platform","description":"Proprietary drug design engine for delivering RNA therapeutics, small molecules, peptides, antibodies, and radioligands to tumors and metastatic sites."},{"name":"TTX-MC138","type":"platform","description":"Lead antisense oligonucleotide therapeutic candidate targeting microRNA-10b to address metastatic cancer across multiple tumor types."},{"name":"TTX-siPDL1","type":"platform","description":"Preclinical siRNA-based modulator of programmed death-ligand 1 (PD-L1) for cancer immunotherapy."},{"name":"TTX-RIGA","type":"platform","description":"Preclinical RNA-based agonist of RIG-I targeting activation of innate immunity in the tumor microenvironment."},{"name":"TTX-siMYC","type":"platform","description":"Preclinical siRNA-based MYC inhibitor for cancer treatment."}],"partnerships":[{"partner_name":"MD Anderson Cancer Center","partnership_type":"strategic","description":"Amended five-year strategic collaboration to focus solely on MD Anderson's participation in the Phase I/II clinical trial of TTX-MC138.","start_date":null},{"partner_name":"Massachusetts General Hospital","partnership_type":"development","description":"Scientific co-founders developed TransCode's initial therapeutic candidate TTX-MC138 at MGH targeting microRNA-10b.","start_date":null}],"affiliations":[],"origin":{"leaf":"401154d7d3f9b52a4b274b1d045a5d5637cb949e474fcc5ce8fb1f35cf2799a9","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"b0af37a09f223e401bf25cba4117873858b1ec32fc8c86954f17bcbb8a2ff1a9","parent":"785137cb253825831f9f531371000c7424b94ce41457d6e71b9d6c9b42fcf94d","source":"0001558370-25-004843","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":250,"hourly_limit":500,"remaining":250,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}